Artiva Biotherapeutics Reports Q3 2024 Financial Results

TipRanksNov 13 23:44 ET

Express News | Needham Reiterates Buy on Artiva Biotherapeutics, Maintains $23 Price Target

BenzingaNov 13 06:17 ET

Artiva Biotherapeutics, Inc.: Strong Buy Rating Supported by Robust Autoimmune Pipeline and Financial Stability

TipRanksNov 13 05:57 ET · Ratings

Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy From TD Cowen

TipRanksNov 12 21:05 ET · Ratings

Express News | Artiva Biotherapeutics Q3 EPS $(0.92) Misses $(0.91) Estimate

BenzingaNov 12 16:51 ET

Artiva Biotherapeutics 3Q Loss/Shr 92c >ARTV

Dow JonesNov 12 16:14 ET